Daisy Y. Shu
8 Macquarie St
Sydney, NSW 2000, Australia
Sydney, NSW 2000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Fumaric Acid Esters as Modulators of Ocular Inflammation and Angiogenesis.
Journal: The American journal of pathology
Published: January 30, 2026
Fumaric Acid Esters as Modulators of Ocular Inflammation and Angiogenesis.
Journal: The American journal of pathology
Published: January 30, 2026
Synergistic cytokine signaling drives angiofibrotic gene pathways in primary human retinal endothelial cells.
Journal: The American journal of pathology
Published: December 19, 2025
Reprogramming Factors Activate a Non-Canonical Oxidative Resilience Pathway That Can Rejuvenate RPEs and Restore Vision.
Journal: bioRxiv : the preprint server for biology
Published: September 15, 2025
Editorial: Multiomics approaches in the central nervous system and neuropathies.
Journal: Frontiers in neuroscience
Published: July 22, 2025
The Future of Ocular Pathobiology: Opportunities and Innovations in the Next Century of Investigative Pathology.
Journal: The American journal of pathology
Published: July 19, 2025
Editorial: Electric stimulation in the eye and brain: advancements and applications.
Journal: Frontiers in cell and developmental biology
Published: June 08, 2025
Dimethyl fumarate is an inhibitor of pathological angiogenesis.
Journal: Cellular signalling
Published: March 16, 2025
Non-invasive bioelectrical therapy suppresses retinal neovascularization by modulating cellular metabolism and inflammation.
Journal: Cell communication and signaling : CCS
Published: March 16, 2025
The Angiofibrotic Switch in Retinal and Choroidal Vascular Diseases: Mechanistic Drivers of Angiogenesis and Endothelial-Mesenchymal Transition.
Journal: The American journal of pathology
Published: January 01, 2025
An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models.
Journal: Science translational medicine
Published: November 27, 2024
The publish or perish game: an interview with the inventor.
Journal: FEBS letters
Published: October 07, 2024
Last Updated: 09/26/2026